This remains an actively moving area, however: on February 27, 2026, the HHS Secretary publicly announced an intent to move roughly 14 of the 19 Category 2-listed peptides, reportedly including ipamorelin and CJC-1295, back toward Category 1 status, and multiple industry and legal-news outlets reported further FDA action in the following months easing Category 2-related restrictions on this group of peptides
Caution: When using nutritional supplements, please inform your healthcare professional if you are undergoing treatment for a medical condition
But these are much less convenient than the self-injector pens I am accustomed to
Travel requires extra precautions Traveling with tirzepatide demands a medical-grade cooler bag with gel ice packs or a portable medication refrigerator
If someone experiences symptoms such as vomiting or severe nausea, they may feel uncertain about whether to take their medication as scheduled
KPV studies examine anti-inflammatory effects during acute injury phases